Literature DB >> 10982008

Analyses of proliferative potential in schwannomas.

M Abe1, T Kawase, M Urano, Y Mizoguchi, M Kuroda, M Kasahara, H Suzuki, T Kanno.   

Abstract

We report studies of schwannomas with a high percentage of MIB-1 positive cells. Thirty-eight specimens from 36 cases of schwannoma in the intracranial and spinal regions comprise the substance of this study. The MIB-1 positive cells were measured using immunohistochemical staining. In nine cases with a positivity index (PI) of 5% or more, immunohistochemical staining using DNA topoisomerase IIalpha (topo-II) and CD68 was performed. In some cases, we also searched for apoptosis with the TdT-mediated dUTP-biotin nick-end labeling (TUNEL) method. Three of nine cases with 5% or more positive MIB-1 cells had a very high cellularity with mitotic figures and were considered cellular Schwannomas. Their MIB-1 PI values were 8.21%, 10.00%, and 21.37%. However, the remaining six cases showed little evidence of malignancy. Their PIs were comparatively low, ranging from 5.19% to 8.41%, and the positive findings were localized in many cases. In these cases, we examined the sites where MIB-1 was measured and found that they corresponded to the borderline site between Antoni type A and B patterns and tended to be associated with an infiltration of CD68-positive macrophage. Furthermore, apoptotic cells appeared in the sites. With topo-II staining, the PIs in the same sites of these six cases were low, ranging from 0.78% to 1.93%. This implies that the high MIB-1 PI that was seen in these six cases was caused by reaction of MIB-1 to tumor cells that brought about an abnormality in the cell cycle by degeneration, such as apoptosis. In the site of formation of Antoni type B, MIB-1 may be a false positive in tumors with degenerative findings such as schwannomas. Topo-II was useful in these cases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10982008     DOI: 10.1007/BF02478916

Source DB:  PubMed          Journal:  Brain Tumor Pathol        ISSN: 1433-7398            Impact factor:   3.298


  4 in total

Review 1.  Pathomechanisms in schwannoma development and progression.

Authors:  Dario-Lucas Helbing; Alexander Schulz; Helen Morrison
Journal:  Oncogene       Date:  2020-07-02       Impact factor: 9.867

2.  Retrospective analysis of the clinical presentation and imaging of eight primary benign mediastinal schwannomas.

Authors:  Ramiro Sandoval-Macias; Irving Daniel Ortiz-Sanchez; Ana Lilia Remirez-Castellanos; Luis Mora-Hernandez; Candelaria Cordova-Uscanga; Alejandra Mantilla-Morales; Tania Alejandra Galindo-Garcia; Armando Gamboa-Dominguez; Fernando Candanedo-Gonzalez
Journal:  BMC Res Notes       Date:  2021-07-21

3.  Expression of VEGF and its receptor genes in intracranial schwannomas.

Authors:  Toshio Uesaka; Tadahisa Shono; Satoshi O Suzuki; Akira Nakamizo; Hiroaki Niiro; Masahiro Mizoguchi; Toru Iwaki; Tomio Sasaki
Journal:  J Neurooncol       Date:  2007-02-14       Impact factor: 4.506

4.  The impact of the MIB-1 index on facial nerve outcomes in vestibular schwannoma surgery.

Authors:  Johannes Wach; Simon Brandecker; Agi Güresir; Patrick Schuss; Hartmut Vatter; Erdem Güresir
Journal:  Acta Neurochir (Wien)       Date:  2020-03-09       Impact factor: 2.216

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.